Abstract
Background: Gastric cancer remains one of the leading causes of cancer-related mortality in Ukraine. The guidelines on diagnosis and treatment of gastric cancer are still undefined within our country thus having poor outcomes. The most frequently used regimen in Ukraine is XELOX, but the latest data suggest to use FLOT regimen. The first one is more convenient from the patient perspective, the second one supposedly has more aggresive toxicity profile with better pathological response. The aim of the study is to define optimal treatment modality for gastric cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
